Following this line of ideas, siRNA-mediated ITGB2-LOF or binase treatment of the SCLC cell line led to the production of EVs that lost the capacity to induce KRAS/MAPK/ERK signaling and SCLC proteins in hPCLS. This evidence concerns the gene KRAS and small cell lung carcinoma.